P4.07D.04 Trofuse-019: A Phase 3 Study of Adjuvant Pembrolizumab with or without Sac-TMTfor Resectable Stage II-IIIB (N2) NSCLC

Autor: LEE, J.M., Liao, B.-C., Spicer, J., Newsom-Davis, T., Hui, R., Xu, Y., Song, A., Samkari, A., Hochmair, M.
Zdroj: In Journal of Thoracic Oncology October 2024 19(10) Supplement:S378-S378
Databáze: ScienceDirect